MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation
Background/Aims Hepatocellular carcinoma (HCC) is a highly heterogeneous disease, and abnormal MET expression plays a crucial role in its progression. However, the specific pathogenic mechanisms of MET in HCC have yet to be fully elucidated. This study aimed to uncover the oncogenic mechanisms of ME...
Gardado en:
| Principais autores: | , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Korean Association for the Study of the Liver
2025-07-01
|
| Series: | Clinical and Molecular Hepatology |
| Assuntos: | |
| Acceso en liña: | http://e-cmh.org/upload/pdf/cmh-2024-1163.pdf |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|